Freddy’s opens at Fort Lee and tests whether military bases can become the next nontraditional growth channel
Freddy’s has opened its first restaurant on a U.S. military base at Fort Lee. Read why this smaller-format move could shape future expansion.
Delska opens 10 MW Riga data center as Latvia pushes for a bigger role in Europe’s AI infrastructure
Delska has launched a 10 MW Riga data center built for AI and HPC. Read why the project could reshape Baltic digital infrastructure ambitions.
Can Kyndryl (NYSE: KD) rebuild trust before its next earnings catalyst?
Kyndryl (NYSE: KD) faces a crucial earnings catalyst. Read what the selloff, AI push, and control issues mean for investors now.
Striveworks lands $70m U.S. govt deal as Pentagon pushes operational AI at scale
Striveworks has secured a $70 million U.S. government deal to scale defense AI deployments. Read what it signals for Pentagon procurement and AI operations.
Commvault Systems (CVLT) brings Hitachi Vantara and NetApp into Flex platform, creating closed-loop ransomware recovery architecture for AI-era enterprises
Commvault expands Flex to Hitachi Vantara and NetApp, creating petabyte-scale ransomware recovery for AI workloads. CVLT trades near 52-week low. Read the full analysis.
Cats finally get a disease-modifying therapy candidate as Gallant pilot data clears the bar and FDA opens the fast lane
Gallant reports positive randomised trial data for feline osteoarthritis stem cell therapy and wins FDA expanded conditional approval eligibility. Read the full analysis.
Sidus Space (NASDAQ: SIDU) strengthens StarVault role as Lonestar scales sovereign data storage network
Sidus Space expands its Lonestar StarVault deal with a second payload order. Read why this could matter for orbital data storage and SIDU stock.
HG Infra Engineering (HGINFRA) wins Rs 519cr Mirzapur thermal power railway contract as stock attempts recovery from 57% decline
HG Infra Engineering (HGINFRA) wins Rs 519.33 crore railway civil works order at Adani Power's Mirzapur thermal plant. Analysis of what it means for investors. Read more.
Immutep (ASX: IMM) surges 48% on FDA orphan drug designation: Is the STS pivot the new thesis?
Immutep (ASX: IMM) jumped 48% after the FDA granted orphan drug status for eftilagimod alfa in soft tissue sarcoma. Here is what the EFTISARC-NEO data means for the investment case.
Nearly 400 US troops wounded and counting as Iran blockade, sanctions escalation deepen conflict
US confirms 399 service members wounded in Iran war as naval blockade of Iranian ports enters force and Treasury reinstates oil sanctions after Islamabad talks collapse.